Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,541 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cognitive behavioural therapy in clozapine-resistant schizophrenia (FOCUS): an assessor-blinded, randomised controlled trial.
Morrison AP, Pyle M, Gumley A, Schwannauer M, Turkington D, MacLennan G, Norrie J, Hudson J, Bowe SE, French P, Byrne R, Syrett S, Dudley R, McLeod HJ, Griffiths H, Barnes TRE, Davies L, Kingdon D; FOCUS trial group. Morrison AP, et al. Among authors: davies l. Lancet Psychiatry. 2018 Aug;5(8):633-643. doi: 10.1016/S2215-0366(18)30184-6. Epub 2018 Jul 11. Lancet Psychiatry. 2018. PMID: 30001930 Free PMC article. Clinical Trial.
Randomised controlled trial of cognitive-behavioural therapy in early schizophrenia: acute-phase outcomes.
Lewis S, Tarrier N, Haddock G, Bentall R, Kinderman P, Kingdon D, Siddle R, Drake R, Everitt J, Leadley K, Benn A, Grazebrook K, Haley C, Akhtar S, Davies L, Palmer S, Faragher B, Dunn G. Lewis S, et al. Among authors: davies l. Br J Psychiatry Suppl. 2002 Sep;43:s91-7. doi: 10.1192/bjp.181.43.s91. Br J Psychiatry Suppl. 2002. PMID: 12271807 Clinical Trial.
Cognitive-behavioural therapy in first-episode and early schizophrenia. 18-month follow-up of a randomised controlled trial.
Tarrier N, Lewis S, Haddock G, Bentall R, Drake R, Kinderman P, Kingdon D, Siddle R, Everitt J, Leadley K, Benn A, Grazebrook K, Haley C, Akhtar S, Davies L, Palmer S, Dunn G. Tarrier N, et al. Among authors: davies l. Br J Psychiatry. 2004 Mar;184:231-9. doi: 10.1192/bjp.184.3.231. Br J Psychiatry. 2004. PMID: 14990521 Clinical Trial.
Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.
Lewis SW, Davies L, Jones PB, Barnes TR, Murray RM, Kerwin R, Taylor D, Hayhurst KP, Markwick A, Lloyd H, Dunn G. Lewis SW, et al. Among authors: davies l. Health Technol Assess. 2006 May;10(17):iii-iv, ix-xi, 1-165. doi: 10.3310/hta10170. Health Technol Assess. 2006. PMID: 16707074 Free article. Clinical Trial.
Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).
Jones PB, Barnes TR, Davies L, Dunn G, Lloyd H, Hayhurst KP, Murray RM, Markwick A, Lewis SW. Jones PB, et al. Among authors: davies l. Arch Gen Psychiatry. 2006 Oct;63(10):1079-87. doi: 10.1001/archpsyc.63.10.1079. Arch Gen Psychiatry. 2006. PMID: 17015810 Clinical Trial.
1,541 results